Cargando…

Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis

Detalles Bibliográficos
Autores principales:	O'Brien, Morgan, Forde, Patrick, Power, Derek, Soden, Declan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288409/ http://dx.doi.org/10.1186/2051-1426-2-S3-P116

Ejemplares similares

Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients
por: Bosch, Ernesto, et al.
Publicado: (2011)

ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
por: O’Brien, Carleigh A., et al.
Publicado: (2020)

Combination therapy with ipilimumab and electrochemotherapy: preliminary efficacy results and correlation with immunological parameters
por: Simeone, Ester, et al.
Publicado: (2014)

Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation
por: Meziani, Lydia, et al.
Publicado: (2023)

Electrochemotherapy for colorectal cancer using endoscopic electroporation: a phase 1 clinical study
por: Falk Hansen, Hanne, et al.
Publicado: (2020)

ICOS Co-Stimulation: Friend or Foe?
por: Wikenheiser, Daniel J., et al.
Publicado: (2016)

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
por: Sharma, P
Publicado: (2014)

Tokenomics: the crypto shift of blockchains, ICOs, and tokens
por: Au, Sean, et al.
Publicado: (2018)

Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
por: Rujas, Edurne, et al.
Publicado: (2020)

Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors
por: Miklavčič, D., et al.
Publicado: (2012)

Plasmacytoid Dendritic Cells and ICOS(+) Regulatory T Cells Predict Poor Prognosis in Gastric Cancer: A Pilot Study
por: Liu, Xiaosun, et al.
Publicado: (2019)

Efficacy of anti-ICOS agonist monoclonal antibodies in preclinical tumor models provides a rationale for clinical development as cancer immunotherapeutics
por: Harvey, Christopher, et al.
Publicado: (2015)

ICO investors
por: Fahlenbrach, Rüdiger, et al.
Publicado: (2020)

Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorly-immunogenic tumors
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Quality of Life with Vulvar Carcinoma Treated with Palliative Electrochemotherapy: The ELECHTRA (ELEctroCHemoTherapy vulvaR cAncer) Study
por: Perrone, Anna Myriam, et al.
Publicado: (2021)

Electrochemotherapy of Tumours
por: Sersa, Gregor, et al.
Publicado: (2008)

Electrochemotherapy of tumours
por: Sersa, G., et al.
Publicado: (2009)

ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4(+) T cells by plasmacytoid dendritic cells
por: Faget, Julien, et al.
Publicado: (2013)

Long-term response after electrochemotherapy in patients with relapsed or refractory cutaneous melanoma
por: Mozzillo, Nicola, et al.
Publicado: (2014)

Inducible Co-Stimulator ICOS Expression Correlates with Immune Cell Infiltration and Can Predict Prognosis in Lung Adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2022)

Antitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma models
por: Campion, Ciorsdan A., et al.
Publicado: (2016)

Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients
por: Hribernik, Andrejc, et al.
Publicado: (2016)

Electrochemotherapy and Other Clinical Applications of Electroporation for the Targeted Therapy of Metastatic Melanoma
por: Cucu, Corina Ioana, et al.
Publicado: (2021)

Electrochemotherapy: An Alternative Strategy for Improving Therapy in Drug-Resistant SOLID Tumors
por: Condello, Maria, et al.
Publicado: (2022)

Colloque ICO '89
por: Moulin, B, et al.
Publicado: (1989)

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade
por: Ralser, Damian J., et al.
Publicado: (2023)

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
por: Solinas, Cinzia, et al.
Publicado: (2020)

Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand
por: Aragoneses‐Fenoll, Laura, et al.
Publicado: (2021)

Electrochemotherapy Causes Caspase-Independent Necrotic-Like Death in Pancreatic Cancer Cells
por: Fernandes, Philana, et al.
Publicado: (2019)

ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo
por: Stoppa, Ian, et al.
Publicado: (2022)

Electrochemotherapy in the treatment of melanoma
por: Wichtowski, Mateusz, et al.
Publicado: (2018)

Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans
por: Spugnini, Enrico P, et al.
Publicado: (2009)

Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers
por: Jarm, Tomaz, et al.
Publicado: (2020)

Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
por: Zhao, Xiashuang, et al.
Publicado: (2023)

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy
por: Mozzillo, Nicola, et al.
Publicado: (2015)

Cnidos v. Cos.
por: Biggart, J. H.
Publicado: (1971)

Hippocrates and the Island of Cos
por: Major, Ralph H.
Publicado: (1941)

The cosπλ theorem
por: Essén, Matts R
Publicado: (1975)

The C.O.S.'s Protest
Publicado: (1890)

Schieffelin & Co’s Extracts
Publicado: (1850)

Cannot write session to /tmp/vufind_sessions/sess_bcpv80mlnsj51oe6ali5jig2bh